Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Stocks plunge on coronavirus fears even as U.S. ramps up fight against spread

Published 02/28/2020, 12:48 AM
© Reuters. Traders work on the floor at the NYSE in New York
US500
-
DJI
-
IXIC
-

By Sinéad Carew and Ted Hesson

NEW YORK/WASHINGTON (Reuters) - U.S. stocks plummeted on Thursday as fears about the effect of the coronavirus outbreak on economic growth flared even as U.S. officials pledged that they were stepping up efforts to safeguard Americans from the virus' spread.

A day after President Donald Trump told Americans that the risk from coronavirus remained "very low," the S&P 500 (SPX) logged its fastest drop of at least 10% in history in a sixth straight day of declines. The broad market average has lost 12% since hitting a record close on Feb. 19.

The Dow (DJI) has fallen as much as 12.9% and the Nasdaq (IXIC) has lost as much as 13%.

Two U.S. officials told Reuters the Trump administration was considering invoking special powers to rapidly expand domestic production of protective masks and clothing to help combat the coronavirus in the United States.

During an interagency call on Wednesday, officials from Health and Human Services (HHS) and the Department of Homeland Security (DHS) discussed the possibility of invoking the Defense Production Act for the manufacture of "personal protective equipment" that can be worn by healthcare workers to prevent infection, according to a DHS official.

A White House official confirmed that the administration was exploring the use of the law to spur manufacturing of protective gear. Both officials requested anonymity to discuss the issue.

Amid a flurry of sometimes contradictory messages from Washington, HHS Secretary Alex Azar late on Thursday proclaimed that "everyday Americans don't need to be worried" about coronavirus. He was quick to add, "But that can change."

During a White House ceremony celebrating Black History Month, Trump countered congressional Democrats' charges that administration preparations were lagging. "Fortunately we made the early moves," Trump said. "It's working out very professionally. We're doing a tremendous job."

Robert Redfield, director of the Centers for Disease Control and Prevention (CDC), told lawmakers the agency revised its criteria for who should be tested for the coronavirus and was shipping more test kits to states.

Redfield also said CDC is investigating how long this virus can survive on surfaces, remaining infectious.

California only has about 200 test kits, an "inadequate" number, but has been in "constant contact with federal agencies" who have promised to send a fresh supply in coming days, Governor Gavin Newsom told a news briefing earlier.

Quick confirmation of coronavirus cases is crucial to rapid response by local health authorities, and states previously reported that some test kits provided by CDC were producing inconclusive results.

Azar told a House of Representatives committee on Thursday that at least 40 public health labs should now be able to test specimens for coronavirus and that could more than double as soon as Friday.

Some state and local public health workers have expressed doubts about how quickly the country will be able to scale up its testing capability, however.

Scott Becker, the CEO of the Association of Public Health Laboratories (APHL), said his group had worked with the CDC and the Food and Drug Administration to develop a way to quickly increase testing capacity but these tests will still have to be validated by states, which could take several days.

"If quality control goes well as expected by the end of next week, upwards of 40 labs will have testing capabilities in addition to the 12 we have," Becker told Reuters.

The number of confirmed U.S. cases is still relatively small at 60, most of them repatriated American passengers from the Diamond Princess cruise ship docked in Japan.

POLITICS

Funding to combat the health crisis has become a political issue in an election year. Trump, a Republican, is seeking $2.5 billion from Congress to boost the government's response. Senate Democratic Leader Chuck Schumer called for $8.5 billion.

Senate Majority Leader Mitch McConnell, a Republican, said he hoped a bipartisan effort could produce a deal on funding within the next two weeks.

China, where the coronavirus started, has borne the brunt of the outbreak, recording nearly 80,000 infections and more than 2,700 deaths. The virus has spread to another 44 countries, where around 3,500 cases and 54 deaths have been reported.

But with new infections reported around the world now surpassing those in mainland China, World Health Organization Director General Tedros Adhanom Ghebreyesus said even rich nations should prepare for surprises.

"No country should assume it won't get cases, that would be a fatal mistake, quite literally," Tedros said.

Various treatments are being tested for the virus, which can lead to pneumonia, but a vaccine may take up to 18 months to develop, health officials have said.

Trump has been increasingly alarmed by market reaction, which he considers a barometer of the economy's health and sees as important to his re-election in November.

© Reuters. Traders work on the floor at the NYSE in New York

(GRAPHIC: Tracking the novel coronavirus - https://graphics.reuters.com/CHINA-HEALTH-MAP/0100B59S39E/index.html)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.